Parkinsonism & Related Disorders
Volume 11, Issue 1 , Pages 1-18 , January 2005

Systemic diseases that cause movement disorders

  • Fernando Alarcón

      Affiliations

    • Department of Neurology, Eugenio Espejo Hospital, P.O. Box 17-07-9515, Quito, Ecuador
    • Corresponding Author InformationCorresponding author. Tel.: +593 2 2221 202/2503 296; fax: +593 2 2505 157.
    • ,
  • Santiago Giménez-Roldán

      Affiliations

    • Department of Neurology, Hospital General Universitario Gregorio Marañón, Doctor Esquerdo 42, 28010 Madrid, Spain

References 

  1. Janavs JI, Aminoff MJ. Dystonia and chorea in acquired systemic diseases. J Neurol Neurosurg Psychiatry. 1998;65:436–445
  2. Hartman A, Oliver P, Oertel WH. Secondary dystonias. J Neurol. 1998;245:511–518
  3. Higgings DS. Chorea and its disorders. Neurol Clin. 2001;19:707–722
  4. Friedman J, Standaert DG. Dystonia and its disorders. Neurol Clin. 2001;19:681–706
  5. Zesiewicz TA, Hauser RA. Phenomenology and treatment of tremor disorders. Neurol Clin. 2001;19:651–680
  6. Blindauer K. Myoclonus and its disorders. Neurol Clin. 2001;19:723–734
  7. Marcus D, Kurlan R. Tics and its disorders. Neurol Clin. 2001;19:735–758
  8. Colcher A, Simuni T. Other Parkinsonian syndromes. Neurol Clin. 2001;19:629–650
  9. Pranzatelli MR. Movement disorders in childhood. Pediatr Rev. 1996;17:388–395
  10. Albin RL. Basal ganglia neurotoxins. Neurol Clin. 2000;18:665–680
  11. Lees AJ. Odd and unusual movement disorders. J Neurol Neurosurg Psychiatry. 2002;72(Suppl 1):117–121
  12. Brew BJ. HIV neurology. New York: Oxford University Press; 2001;
  13. Cardoso F. Infectious and transmissible movement disorders. In:  Jankovic J,  Tolosa E editor. Parkinson's disease and movement disorders. 4th ed. Philadelphia: Lippincott Williams & Williams; 2002;
  14. Nath A, Jankovic J, Pettigrew C. Movement disorders and AIDS. Neurology. 1987;37:37–41
  15. Mirsattari SM, Roke Berry ME, Holden JK, Ni W, Nath A, Power C. Paroxysmal dyskinesias in patients with HIV infection. Neurology. 1999;52:109–114
  16. Elder G, Sever JL. Neurologic disorders associated with AIDS retroviral infection. Rev Infect Dis. 1988;10:286–302
  17. Berger JR, Moskowitz L, Fisch L, Kelley RE. The neurologic complications of the acquired immunodeficiency syndrome. Neurology. 1984;34(Suppl 1):134–135
  18. Metzer WS. Movement disorders with AIDS encephalopathy: case report. Neurology. 1987;37(1):438
  19. Piccolo I, Causarano R, Sterzi R, Sberna M, Oreste PL, Maioli C, et al. Chorea in patients with AIDS. Acta Neurol Scand. 1999;100:332–336
  20. Piccolo I, Sterzi R, Thiella G, Minazzi MS, Caraseni T. Sporadic choreas: analysis of a general hospital series. Eur Neurol. 1999;41:143–149
  21. Carranza EJ, Rossitch E, Samuels MA. Parkinsonian symptoms in a patient with AIDS and cerebral toxoplasmosis. J Neurol Neurosurg Psychiatry. 1989;52:445–446
  22. Hirose G. Parkinsonism in a patient with AIDS. Intern Med. 2000;39:1006–1007
  23. Maggi P, de Mari M, Moramarco A, Fiorentino G, Lamberti P, Angarano G. Parkinsonism in a patient with AIDS and cerebral opportunistic granulomatous lesions. Neurol Sci. 2000;21:173–176
  24. Mirsattari SM, Power C, Nath A. Parkinsonism with HIV infection. Mov Disord. 1998;13:684–689
  25. Cornford ME, Holden JK, Boyd MC, Berry K, Vinters HV. Neuropathology of the acquire immunodeficiency syndrome (AIDS). Acta Neuropathol. 1991;82:39–44
  26. Kieburtz KD, Epstein LG, Gelbard HA. Excitoxicity and dopaminergic dysfunction in the acquired immunodeficiency syndrome dementia complex: therapeutic implications. Arch Neurol. 1991;48:1281–1284
  27. Tanaka M, Endo K, Suzuki T, Kakita A, Takahashi H, Sata T. Parkinsonism in HIV encephalopathy. Mov Disord. 2000;15:1032–1033
  28. Hersh BP, Rejendran PR, Battinelli O. Parkinsonism as the presenting manifestation of HIV infection: improvement on HAART. Neurology. 2001;56:278–279
  29. Sacktor NC, Skolasky RL, Lyles RH, Esposito D, Selnes OA, McArthur JC. Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. J Neurovirol. 2000;6:84–88
  30. Kalita J, Misra UK. Markedly severe dystonia in Japanese encephalitis. Mov Disord. 2000;15:1168–1172
  31. Misra UK, Kalita J. Prognosis of Japanese encephalitis patients with dystonia compared to those with Parkinsonian features only. Postgrad Med J. 2002;78:238–241
  32. Murgod UA, Muthane UB, Ravi V, Radhesh S, Desai A. Persistent movement disorders following Japanese encephalitis. Neurology. 2001;57:2313–2315
  33. Pradhan S, Pandey N, Shashank S, Gupta RK, Mathur A. Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis. Neurology. 1999;53:1781–1786
  34. Kalita J, Das BK, Misra UK. SPECT studies of regional cerebral blood flow in 8 patients with Japanese encephalitis in subacute and chronic stage. Acta Neurol Scand. 1999;99:213–218
  35. von Economo C. Encephalitis lethargica. Wien Klin Weshr. 1917;30:581–583
  36. Casals J, Elizan TS, Yahr MD. Postencephalitic Parkinsonism: a review. J Neurol Transm. 1998;105:645–676
  37. Reid AH, McCall S, Henry JM, Taubenberger JK. Experimenting on the past: the enigma of von Economo's encephalitis lethargica. J Neuropathol Exp Neurol. 2001;60:663–670
  38. McCall S, Henry JM, Reid AH, Taubenberger JK. Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic Parkinson cases. J Neuropathol Exp Neurol. 2001;60:696–704
  39. Vincent A. Encephalitis lethargica: part of a spectrum of post-streptococcal autoimmune diseases?. Brain. 2004;127:1–3
  40. Dale RC, Church AJ, Surtees RAH, Lees AJ, Adcock JE, Harding B, et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain. 2004;127:21–33
  41. Kiley M, Esiri MM. A contemporary case of encephalitis lethargica. Clin Neuropathol. 2001;20:2–7
  42. Haraguchi T, Ishizu H, Terada S, Takehisa Y, Tanabe Y, Nishinaka T, et al. An autopsy case of postencephalitic Parkinsonism of von Economo type: some new observations concerning neurofibrillary tangles and astrocytic tangles. Neuropathology. 2000;20:143–148
  43. Ghaemi M, Rudolf J, Schmulling S, Bamborschike S, Heiss WD. FDG-and Dopa-PET in postencephalitic Parkinsonism. J Neurol Transm. 2000;107:1289–1295
  44. Caparros-Lefebvre D, Cabaret M, Godefroy O, Steinling M, Remy P, Samson Y, et al. PET study and neuropsychological assessment of a long-lasting post-encephalitic Parkinsonism. J Neurol Transm. 1998;105:489–495
  45. McAuley J, Shahmanesh M, Swash M. Dopaminergic therapy in acute encephalitis lethargica. Eur J Neurol. 1999;6:235–237
  46. Gollomp SM, Fahn S. Transient dystonia as a complication of varicella. J Neurol Neurosurg Psychiatry. 1987;50:1228–1229
  47. Hargrave DR, Webb DW. Movement disorders in association with Herpex Simplex virus encephalitis in children: a review. Dev Med Child Neurol. 1998;40:640–642
  48. Verna A, Brozman B. Opsoclonus–myoclonus syndrome following Epstein-Barr virus infection. Neurology. 2002;58:1131–1132
  49. Giménez Roldán S. Neuropharmacology and treatment of myoclonus. In:  Jankovic J,  Tolosa E editor. Parkinson's disease and movement disorders. 4th ed. Philadelphia: Lippincott Williams & Williams; 2002;
  50. Church AJ, Cardoso F, Dale RC, Lees AJ, Thompson EJ, Giovannoni G. Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology. 2002;59:227–231
  51. Swedo SE. Sydenham's chorea: a model for childhood autoimmune neuropsychiatric disorders. JAMA. 1994;272:1788–1791
  52. Cardoso F, Eduardo C, Silva AP, Mota CCC. Chorea in fifty consecutive patients with rheumatic fever. Mov Disord. 1997;12:701–703
  53. Cardoso F, Vargas AP, Oliveira LD, Guerra AA, Amoral SV. Persistent Sydenham's chorea. Mov Disord. 1999;14:805–807
  54. Murphy TK, Petitto JM, Voeller KK, Goodman WK. Obsessive compulsive disorder. Is there an association with childhood streptococcal infections and altered immune function?. Semin Clin Neuropsychiatry. 2001;6:266–276
  55. Murphy TK, Goodman WK, Ayoub EM, Voeller KK. On defining Sydenham's chorea: where do we draw the line?. Biol Psychiatry. 2000;47:851–857
  56. Kurlan R, The PANDAS. hypothesis: losing its bite?. Mov Disord. 2004;19:371–374
  57. Leonard HL, Swedo SE. Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS). J Neuropsychopharmacol. 2001;4:191–198
  58. Church AJ, Dale RC, Lees AJ, Giovannoni G, Robertson MH. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry. 2003;74:602–607
  59. Muller N, Kroll B, Schwarz MJ, Riedel M, Straube A, Lutticken R, et al. Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette's syndrome. Psychiatry Res. 2001;25:187–193
  60. Osontokun BO, Adeuja AOG, Familusi JB. Tuberculous meningitis in Nigerians: a study of 194 patients. Trop Geogr Med. 1971;23:225–231
  61. Alarcón F, Dueñas G, Cevallos N, Lees AJ. Movement disorders in 30 patients with tuberculous meningitis. Mov Disord. 2000;561–569
  62. Sing RG, Sonani PN, Sharma BM, Mishra J, Gupta PR. A clinical and bacteriological study of tuberculous meningitis. J Assoc Phys India. 1980;28:457–462
  63. Thomas MD, Chopra JS, Walia BNS. Tuberculous meningitis (a clinical study of 232 cases). J Assoc Phys India. 1977;25:633–639
  64. Udani PM, Parekh UC, Dastur DK. Neurological and related syndromes in CNS tuberculosis (clinical features and pathogenesis). J Neurol Sci. 1971;14:341–357
  65. Babikian VL, Heydemann PT, Swisher CN. Extrapyramidal movements in a patient with tuberculous meningitis. Clin Pediatr. 1985;24:113–115
  66. Leiguarda R, Berthier M, Starkstein S, Nogués M, Lylyk P. Ischemic infarction in 25 children with tuberculous meningitis. Stroke. 1988;19:200–204
  67. Riela A, Roach S. Choreoathetosis in an infant with tuberculous meningitis. Arch Neurol. 1982;39:596
  68. Alarcón F. Movimientos anormales en las enfermedades infecciosas. VIII Pan-American congress of neurology proceedings, October 6–12, 1991, Montevideo, Uruguay.
  69. Alarcón F. Movement disorders in 14 patients with cerebral tuberculomas. Nova Science; 2004;in press
  70. Alarcón F, Tolosa E, Muñoz E. Focal limb dystonia in a patient with a cerebellar mass. Arch Neurol. 2001;58:1125–1127
  71. Alarcón F, Calderón L, Bara ME. Manejo médico de la hidrocefalía tuberculosa. Arch Neurobiol (Madrid). 1985;48:133–136
  72. Dalaporte P, Salama J, Amarenco P. Subthalamic tuberculoma disclosed by hemiballism: efficacy of antituberculous treatment. Ann Med Intern (Paris). 1983;134:728–731
  73. Alarcón F, Escalante L, Pérez Y, Banda H, Chacón G, Dueñas G. Tuberculous meningitis: short course of chemotherapy. Arch Neurol. 1990;47:1313–1317
  74. Alarcón F, Cevallos N, Narvaez B. Meningitis tuberculosa: un viejo y nuevo problema. Rev Ecuat Neurol. 1994;3:39–54
  75. Beskind DL, Keim SM. Choreoathetotic movement disorder in a boy with mycoplasma pneumoniae. Ann Emerg Med. 1994;23:1375–1378
  76. Bamford JM, Hakin RN. Chorea after legionnaire's disease. BMJ. 1982;284:1232–1233
  77. Jones AL, Bouchier IA. A patient with neurosyphilis presenting as chorea. Scott Med J. 1993;38:82–84
  78. Ryan MM, Procopis PG, Ouvier RA. Influenza A encephalitis with movement disorders. Pediatr Neurol. 1999;21:669–673
  79. Kumar A. Movement disorders in the tropics. Parkinsonism Relat Disord. 2002;9:69–75
  80. Vukelic D, Bozinovic D, Morovic M, Tesovig G, Ruzic Sabijic E, Barisic N, et al. Opsoclonus–myoclonus syndrome in a child with neuroborreliosis. Infection. 2000;40:189–191
  81. Garg RH, Karak B, Misra S. Neurological manifestations of malaria: an update. Neurol India. 1999;47:1–7
  82. Senenayake N, de Silva HJ. Delayed cerebellar ataxia complicating falciparum malaria: a clinical study of 74 patients. J Neurol. 1994;241:456–459
  83. Motiana R, Agarwal S, Saifee AA, Bordia A. Opsoclonus–ataxia as an unusual presentation of malaria. Neurol India. 1991;39:39–40
  84. Thi Hoang NT, J Day NP, Van Chuong L, Waller D, Hoan Phu N, Bethell DB, et al. Post-malaria neurological syndrome. Lancet. 1996;348:917–921
  85. Verma A, Berger JR, Bowen BC, Sánchez-Ramos J. Reversible Parkinsonian syndrome complicating cysticercus midbrain encephalitis. Mov Disord. 1995;10:215–219
  86. Alarcón F. Movement disorders in neurocysticercosis: report of 15 patients. Nova Science; 2004;in press
  87. Keane JR. Tremor as the result of shunt obstruction: four patients with cysticercosis and secondary Parkinsonism: report of four cases. Neurosurgery. 1995;37:520–522
  88. Puri V, Chowdbury V, Gulati P. Myoclonus: a manifestation of neurocysticercosis. Postgrad Med J. 1991;67:68–69
  89. Bhigjee AL, Kemp T, Cosmett JE. Cerebral cysticercosis presenting with hemichorea. J Neurol Neurosurg Psychiatry. 1987;50:1561–1562
  90. Sawhney IMS, Singh G, Lekhra OP, Mathuriya SN, Parihar PS, Prabhakar S. Uncommon presentations of neurocysticercosis. J Neurol Sci. 1998;154:94–100
  91. Tieve HAG, Zanatta A, Germiniani FMB, Almeida SM, Werneck LC. Holmes tremor andneuroparacoccidioidomycosis: a case report. Mov Disord. 2002;17:1392–1394
  92. Alarcón F, Hidalgo F, Moncayo J, Viñán I, Dueñas G. Cerebral cysticercosis and stroke. Stroke. 1992;23:224–228
  93. Alarcón F, Vanormelingen K, Moncayo J, Viñán I. Cerebral cysticercosis as a risk factor for stroke in young and middle-aged people. Stroke. 1992;23:224–228
  94. Alarcón F, Escalante L, Dueñas G, Montalvo M, Román M. Neurocysticercosis: short course of treatment with albendazole. Arch Neurol. 1989;46:1231–1236
  95. Alarcón F. Albendazole therapy for neurocysticercosis. Arch Neurol. 1990;47:1278–1279
  96. Alarcón F, Zijlmans JCM, Dueñas G, Cevallos N. Post-stroke movement disorders: report of 56 patients. J Neurol Neurosurg Psychiatry. 2004;75:1568–1740
  97. Obeso JA, Gimenez-Roldán S. Clinicopathological correlation in symptomatic dystonia. Adv Neurol. 1998;50:113–122
  98. Bhatia KP, Marsden CD. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain. 1994;117:859–876
  99. Grimes JD, Hassan MN, Quarrington AM, D'Alton J. Delayed onset posthemiplegic dystonia: CT demonstration of basal ganglia pathology. Neurology. 1982;32:1033–1035
  100. Keane JR, Young JA. Blepharospasm with bilateral basal ganglia infarction. Arch Neurol. 1985;42:1206–1208
  101. Jacob PC, Pratap CR. Blepharospasm and jaw closing dystonia after parietal infarcts. Mov Disord. 1995;10:794–802
  102. Kwak C, Jankovic J. Tourettism and dystonia after subcortical stroke. Mov Disord. 2002;17:821–825
  103. Demierre B, Rondot P. Dystonia caused by putamino-capsulo-caudate vascular lesions. J Neurol Neurosurg Psychiatry. 1983;46:404–409
  104. Burton KM, Farrell K, Li D, Calne DB. Lesions of the putamen and dystonia: CT and magnetic resonance imaging. Neurology. 1984;34:962–965
  105. Muñoz JE, Tolosa E, Saiz A, Vila N, Mari MJ, Blesa R. Upper limb dystonia secondary to a mid-brain hemorrhage. Mov Disord. 1996;11:96–99
  106. Schwartz M, de Deyn PP, Van den Kerchove M, Pickut BA. Cervical dystonia as a probable consequence of focal cerebral lesion. Mov Disord. 1995;10:797–798
  107. Moiho ES, Factor SA. Basal ganglia infarction as a possible cause of cervical dystonia. Mov Disord. 1993;8:213–216
  108. Jankovic J, Shutish C. Blepharospasm associated with brain stem lesions. Neurology. 1983;33:1237–1240
  109. Hartmann A, Pogarell O, Oertel WH. Secondary dystonias. J Neurol. 1998;245:511–518
  110. Pettigrew LG, Jancovic J. Hemidystonia: a report of 22 patients and a review of the literature. J Neurol Neurosurg Psychiatry. 1985;48:650–657
  111. Martín TP, Akoek NS. Hemichorea associated with a lesion of corpus luysii. Brain. 1934;57:504–505
  112. Chung SJ, Im J-H, Lee MC, Kim JS. Hemichorea after stroke: clinical radiological correlation. J Neurol. 2004;251:725–729
  113. Dewey RB, Jankovic J. Hemiballism†hemichorea: clinical and pharmacological findings in 21 patients. Arch Neurol. 1989;46:862–867
  114. Lee MS, Marsden CD. Movement disorders following lesions of the thalamus or subthalamic region. Mov Disord. 1994;9:493–507
  115. Kase CS, Maulsey GO, deJuan E, Mohr JP. Hemichorea–hemiballism and lacunar infarction in the basal ganglia. Neurology. 1981;31:452–455
  116. Kim JS. Delayed onset of mixed involuntary movements after thalamic stroke: clinical, radiological and pathophysiological findings. Brain. 2001;124:299–309
  117. Srinivas K, Rao VM, Subbulaskshmi N, Braskaran J. Hemiballism after striatal hemorrhage. Neurology. 1987;37:1428–1429
  118. Ballism GF. In:  Jankovic J,  Tolosa E editor. Parkinson's disease and movement disorders. 4th ed. Philadelphia: Lippincott Williams & Williams; 2002;
  119. Diersen G, Gioino G. Correlación anatómica del hemibalismo. Revista Clínica Española. 1961;82:280–305
  120. Dethy S, Luxen A, Bidaut LM, Goldman S. Hemibody tremor related to stroke. Stroke. 1993;24:2094–2096
  121. Miwa H, Hatori K, Kondo T, Imai H, Mizuna Y. Thalamic tremor: case reports and implications of the tremor: generating mechanism. Neurology. 1996;46:75–79
  122. Otto S, Buttner T, Schols L, Windmeir DT, Przuntek H. Head tremor due to bilateral thalamic and midbrain infarction. J Neurol. 1995;242:608–611
  123. Ghika J, Bogousslavky J, Henderson J, Maeder P, Regli F. The ‘jerky dystonic unsteady hand’: a delayed motor syndrome in posterior thalamic infarctions. J Neurol. 1994;241:537–542
  124. Kim JS. Delayed onset hand tremor caused by cerebral infarction. Stroke. 1992;23:292–294
  125. Kim JS. Writing tremor after discrete cortical infarction. Stroke. 1994;25:2280–2282
  126. Ferbert A, Gerwig M. Tremor due to stroke. Mov Disord. 1993;8:179–182
  127. Mossutto-Agatiello L, Pucceti G, Castellano AE. ‘Rubral tremor’ after thalamic hemorrhage. J Neurol. 1993;241:27–30
  128. Lee MS, Lee SA, Heo JH, Choi IS. A patient with a resting tremor and a lacunar infarction at the border between the thalamus and the internal capsule. Mov Disord. 1993;8:244–246
  129. Kim JS. Involuntary movements after anterior cerebral artery territory infarction. Stroke. 2001;32:258–261
  130. Tolosa E, Santamaría J. Parkinsonism and basal ganglia infarcts. Neurology. 1984;34:1516–1518
  131. Winikates J, Jankovic J. Clinical correlates of vascular Parkinsonism. Arch Neurol. 1999;56:98–102
  132. Defer GL, Remy P, Malapert D, Ricolfi F, Samson Y, Degos JD. Rest tremor and extrapyramidal symptoms after midbrain hemorrhage: clinical and 18 F-Dopa PET evaluation. J Neurol Neurosurg Psychiatry. 1994;57:987–989
  133. Kulisevsky J, Berthier ML, Avila A, Roig C. Unilateral Parkinsonism and stereotyped movements following a right lenticular infarction. Mov Disord. 1996;11:752–754
  134. Kulisevsky J, Avila A, Berthier ML. Bipolar affective disorder and unilateral Parkinsonism after a brainstem infarction. Mov Disord. 1995;10:802
  135. Friedman A, Kang UJ, Tatemichi TK, Burke RE. A case of Parkinsonism following striatal lacunar infarction. J Neurol Neurosurg Psychiatry. 1986;49:1087–1088
  136. Tison F, Duché B, Loiseau P. Syndrome hemiparkinsonien vasculaire. Rev Neurol (Paris). 1999;149:565–567
  137. De la Fuente Fernández R, López JM, Rey del Corral P, de la Iglesia Martínez F. Peduncular hallucinosis and right hemiParkinsonism caused by left mesencephalic infarction. J Neurol Neurosurg Psychiatry. 1994;57:870
  138. Fénélon G, Gray F, Wallays C, Poirier J, Guillard A. Parkinsonism and dilatation of the perivascular spaces (‘état cribé’) of the striatum: a clinical, MRI and pathological study. Mov Disord. 1995;10:754–760
  139. Fénélon G, Houéto J-L. Unilateral Parkinsonism following a large infarct in the territory of the lenticulostriate arteries. Mov Disord. 1997;12:1086–1090
  140. Murrow RW, Schweiger GD, Kepes JJ, Koller WC. Parkinsonism due to a basal ganglia lacunar state: clinicopathological correlation. Neurology. 1990;40:897–900
  141. Zijlmans JC, Thijssen HO, Vogels OJ, Kremer HP, Poels PJ, Schoonderwaldt HC, et al. MRI in patients with suspected vascular Parkinsonism. Neurology. 1995;45:2183–2188
  142. Johansson BB. Brain plasticity and stroke rehabilitation: the Willis lecture. Stroke. 2000;31:223–230
  143. Hawker K, Lang AE. Hypoxic ischemic damage of the basal ganglia: case report and review of the literature. Mov Disord. 1990;5:219–224
  144. Przedborski S, Kostic VN, Burke RE. Delayed onset dyskinesias. Neurology. 1996;47:1358–1359
  145. Burke RE, Franklin SD, Inturrisi CE. Acute and persistent suppression of preproenkephalin in RNA expression in the striatum following developmental hypoxic-ischemic injury. J Neurochem. 1994;62:1878–1886
  146. Scott BL, Jankovic J. Delayed-onset progressive movement disorders after static brain lesions. Neurology. 1996;48:68–74
  147. Jiménez-Jiménez FJ, Burguera JA, Catalán MJ, Vázquez A, Vaamonde J, Vela-Desajo L, et al. Delayed-onset dystonia in patients with antecedents of perinatal asphyxia. Parkinsonism Relat Disord. 1997;3:21–25
  148. Barraquer-Bordas L. Sobre la evolución clínica de algunos síndromes extrapiramidales de instauración infantil. Prensa Med Argent. 1966;53:123–129
  149. Burke RE, Fahn S, Gold AP. Delayed-onset dystonia in patients with ‘static’ encephalopathy. J Neurol Neurosurg Psychiatry. 1980;43:789–797
  150. Carpenter MB. Athetosis and the basal ganglia. Arch Neurol Psychiatry. 1977;63:875–901
  151. Kupsky WJ, Drozd MA, Barlow CF. Selective injury of the globus pallidus in children with post-cardiac surgery choreic syndrome. Dev Med Child Neurol. 1995;35:135–144
  152. Bhatt MH, Obeso JA, Marsden CD. Time course of postanoxic akinetic-rigid and dystonic syndromes. Neurology. 1933;43:314–317
  153. Vannucci RC. Mechanisms of perinatal hypoxic–ischemic brain damage. Semin Perinatol. 1993;17:330–337
  154. Poser JB. Paraneoplastic syndromes. Rev Neurol (Paris). 2002;158:899–906
  155. Alamowitch S, Graus F, Uchuya M, Reñé R, Bescansa E, Delattre JY. Limbic encephalitis and small cell lung carcinoma. Clinical and immunological features. Brain. 1997;120:923–928
  156. Gouider-Khouja N, Mekaouar A, Larnaut A, Miladi N, Khelifa FB, Hentati F. Progressive encephalomyelitis with rigidity presenting as a stiff-person syndrome. Parkinsonism Relat Disord. 2002;8:285–288
  157. Casado JL, Gil-Peralta A, Graus F, Arenas C, López JM, Alberca R. Anti-Ri antibodies associated with opsoclonus and progressive encephalomyelitis with rigidity. Neurology. 1994;44:1521–1522
  158. Barker RA, Revesz T, Thompson M, Marsden CD, Brown P. Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry. 1998;65:633–640
  159. Rodríguez-Barrionuevo AC, Caballero M, Delgado MP, Mora MD, Martínez-Antón J. Síndrome de Kirnsbourne: revisión de nuestros casos. Rev Neurol (Barc). 1998;154:956–959
  160. Connolly A, Pstronk A, Mehta S, Prazantelli MR, Noetzel M. Serum autoantibodies in childhood opsoclonus–myoclonus syndrome: an analysis of antigenic targets in neural tissues. J Pediatr. 1997;130:878–884
  161. Gobbi G, Melideo G, Rossi PG. The effect of intravenous L-5-HTP in the myoclonic encephalopathy of infants. Neuropediatrics. 1986;17:63–65
  162. Prazantelli MR. The immunopharmacology of the opsoclonus–myoclonus syndrome. Clin Neuropharmacol. 1996;19:1–47
  163. Prazantelli MR, Tate ED, Galván I, Wheeler A. Controlled pilot study of piracetam for pediatric opsoclonus–myoclonus. Clin Neuropharmacol. 2001;24:352–357
  164. Koh PS, Raffensperger JG, Berry S, Larsen MB, Johnstone HS, Chou P, et al. Long-term outcome in children with opsoclonus–myoclonus and ataxia and coincident neuroblastoma. J Pediatr. 1994;125:712–716
  165. Bataller L, Graus F, Saíz A, Vilchez JJ. for the Spanish opsoclonus–myoclonus study group. Clinical outcome in adult-onset idiopathic or paraneoplastic opsoclonus–myoclonus. Brain. 2001;124:437–443
  166. Luque FA, Furneaux HM, Ferziger R, Rosenblum MK, Wray SH, Schold SC, et al Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol. 1991;29:241–251
  167. Jongen JL, Moll WJ, Silevis Smitt PA, Vetch CJ, Tijssen CC. Anti-Ri positive opsoclonus–myoclonus–ataxia in ovarian duct cancer. J Neurol. 1998;245:691–692
  168. Wirtz PW, Silevis Smitt PA, Hoff JL, de Leeuw B, Lammers GJ, Van Duinen SG, et al. Anti-Ri antibody positive opsoclonus–myoclonus in a male patients with breast carcinoma. J Neurol. 2002;249:1710–1712
  169. Hormigo A, Dalmau J, Rosenblum MK, River ME, Posner JB. Immunological and pathological study of anti-Ri associated encephalopathy. Ann Neurol. 1994;36:896–902
  170. Kay CL, Davies-Jones GAB, Singal R, Winfield DA. Paraneoplastic opsoclonus–myoclonus in Hodgkin's disease. J Neurol Neurosurg Psychiatry. 1993;56:831–832
  171. Hersch B, Dalmau J, Dangond F, Gultekin S, Geller E, Wen PY. Paraneoplastic opsoclonus–myoclonus associated with anti-Hu antibodies. Neurology. 1994;44:1754–1755
  172. Moretti R, Torre P, Antonello RM, Nasuelli D, Cazzato G. Opsoclonus–myoclonus syndrome: gabapentine as a new therapeutic proposal. Eur J Neurol. 2000;7:455–456
  173. Meinck H-M, Thompson PD. Stiff man syndrome and related conditions. Mov Disord. 2002;17:853–866
  174. Hagiwara H, Enomoto-Nakatani S, Sakai K, Ugawa Y, Kunusoki S, Kanazawa I. Stiff-person syndrome associated with invasive tymoma. J Neurol Sci. 2001;193:59–62
  175. Vallderiola F. Movement disorders of autoimmune origin. J Neurol. 1999;246:423–431
  176. Antoine JC, Absi L, Honorat J, Boulesteix J-M, de Bouker T, Vial C, et al. Antiaphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumours. Arch Neurol. 1999;56:172–177
  177. Brown P, Rothwell JR, Marsden CD. The stiff leg syndrome. J Neurol Neurosurg Psychiatry. 1997;62:31–37
  178. Silverman IE. Paraneoplastic stiff limb syndrome. J Neurol Neurosurg Psychiatry. 1999;67:126–127
  179. Vermino S, Tuite P, Adler CH, Meschia JF, Boeve BF, Parisi JE, et al. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol. 2002;51:625–630
  180. Kujawa KA, Niemi VR, Tomasi MA. Ballistic-choreic movements as the presenting feature of renal cancer. Arch Neurol. 2001;58:1133–1135
  181. Nuti A, Ceravolo R, Salvetti S. Paraneoplastic choreic syndrome during non-Hodgkin's lymphoma. Mov Disord. 2000;15:350–352
  182. Sheen VL, Asimakopoulos F, Heyman E, Henderson G, Feske SK. Hemichorea as a presentation of recurrent non-Hodgkin's lymphoma. J Neurol. 2002;249:1746–1748
  183. Albin RL, Bromberg MB, Penney JB, Knapp R. Chorea and dystonia: a remote effect of carcinoma. Mov Disord. 1988;3:162–169
  184. Heckman JG, Lang CJG, Druschky A, Claus D, Bartels D, Neundorfer B. Chorea resulting from paraneoplastic encephalitis. Mov Disord. 1997;12:464–466
  185. Golbe LI, Miller DC, Duvoisin RC. Paraneoplastic degeneration of the substantia nigra with dystonia and Parkinsonism. Mov Disord. 1989;4:147–152
  186. Simonetti F, Oergami P, Aktipi GM, Giardini G, Ceroni M, Lattuada P, et al. Paraneoplastic ‘rubral’ tremor: a case report. Mov Disord. 1998;13:612–631
  187. García-Barragán N, Plaza JF, de Lucas P, Masjuan J. Síndrome cerebeloso y mioclonías en un enfermo con adenocarcinoma de colon. Rev Neurol (Barc). 2001;32:440
  188. Vigliani MC, Palmucci L, Polo P, Mutano R, Schiffer D, de Luca S, et al. Paraneoplastic myoclonus associated with renal cell carcinoma and response to tumour ablation. J Neurol Neurosurg Psychiatry. 2002;70:814–815
  189. Roobol TH, Kazzaz BA, Vetch CHJ. Segmental rigidity and spinal myoclonus as a paraneoplastic syndrome. J Neurol Neurosurg Psychiatry. 1987;50:628–631
  190. Greenhouse AH. On chorea, lupus erythematosus and cerebral arteritis. Arch Intern Med. 1966;117:389–393
  191. Bruyn GW, Padberg G. Chorea and systemic lupus erythematosus. Eur Neurol. 1984;23:278–290
  192. Heilman KM, Koller WC, LeMaster PC. Haloperidol treatment of chorea associated with systemic lupus erythematosus. Neurology. 1971;21:963–965
  193. Gutman M, Lang AE, Garnett ES, Nahmias C, Firnau G, Tyndel EJ, et al. Regional cerebral glucose metabolism in SLE chorea: further evidence that striatal hypometabolism is not a correlate of chorea. Mov Disord. 1987;2:201–210
  194. Bauer FK, Riley C, Cohen EB. Disseminated lupus erythematosus. Sydenham's chorea and rheumatic heart disease: report of a case with autopsy. Ann Intern Med. 1950;33:1042–1053
  195. Kune K, Kurahashi K, Nakano I, Morimatuse Y, Takemori H. A neuropathological study of a case of lupus erythematosus with chorea. J Neurol Sci. 1994;123:59–63
  196. Jankovic J, Patten BM. Blepharospasm and autoimmune diseases. Mov Disord. 1987;2:159–163
  197. García-Moreno JM, Chacón J. Juvenile Parkinsonism as a manifestation of systemic lupus erythematosus: a case report and review of the literature. Mov Disord. 2002;17:1329–1335
  198. Bodiguel E. Anticorps anti-phospholipides et système nerveux central. Rev Neurol (Paris). 1992;148:652–655
  199. Hodges JR. Chorea and the lupus anticoagulant. J Neurol Neurosurg Psychiatry. 1987;50:368–369
  200. Sundén-Culberg J, Tedroff J, Aquilonius S-M. Reversible chorea in primary antiphospholipid syndrome. Mov Disord. 1988;13:147–149
  201. Cervera R, Asheron R, Font J. Chorea in the antiphospholipid syndrome: clinical, radiologic, and immunologic characteristics of 50 patients from our clinic and the recent literature. Medicine. 1997;76:203–212
  202. Milanov I, Bogdanova D. Antiphospholipid syndrome and dystonia–Parkinsonism. Parkinsonism Relat Disord. 2002;8:215
  203. Furie R, Ishikawa T, Thawan V, Eidelberg TD. Alternating hemichorea in primary antiphospholipid syndrome: evidence for contralateral striatal hypermetabolism. Neurology. 1994;44:2197–2199
  204. Adhiyaman V, Meara RJ, Bhowmick BK. Antiphospholipid syndrome and dystonia–Parkinsonism. Parkinsonism Relat Disord. 2002;8:215
  205. Stone LA, Armstrong RM. An unusual presentation of diabetes: hyperglycemia inducing hemiballism. Ann Neurol. 1989;8:215
  206. Linazasoro G, Urtasun M, Poza JJ, Suares JA, Martí-Massó JF. Generalized chorea induced by nonketotic hyperglycemia. Mov Disord. 1993;8:119–120
  207. Ahlskog JE, Nishino H, Evidente VGH, Tulloch JW, Forbes GS, Caviness JN, et al. Persistent chorea triggered by hyperglycemic crisis in diabetics. Mov Disord. 2001;16:890–898
  208. Matsuda M, Shimizu Y, Watabe O, Hattori KI, Hashimoto T, Ikeda S. Coexistence of hemidystonia and hemiballism in a diabetic patient with striatal hyperintensity on T1-weighted MRI. J Neurol. 2001;248:1096–1098
  209. Hashimoto T, Hanyu N, Yahikozawa H, Yanagisawa N. Persistent hemiballism with striatal hyperintensity on T1-weighted MRI in a diabetic patient: 6 years follow-up study. J Neurol Sci. 1999;165:178–181
  210. Lai P-H, Tien RD, Chang M-H, Teng MMH, Yang C-F, Pan H-B, et al. Chorea–ballismus with nonketotic hyperglycemia in primary diabetes mellitus. AJNR. 1996;17:1057–1064
  211. Ohara S, Nakagawa S, Tabata K, Hashimoto T. Hemiballism with hyperglycemia and striatal T1-MRI hyperintensity: an autopsy report. Mov Disord. 2001;16:521–525
  212. Chu K, Kang D-W, Kim D-E, Park S-H, Roh J-K. Diffusion-weighted and gradient echo magnetic resonance findings of hemichorea–hemiballismus associated with diabetic hyperglycemia. Arch Neurol. 2002;59:448–452
  213. Boukriche Y, Masson C, Gervais H, Dehen H. Hémichorée, hémiballisme révélataurs d'une hyperglycémie sans cétose. Rev Neurol (Paris). 2001;157:1420–1422
  214. Evidente VGH, Gwinn-Hardy K, Caviness JN. Risperidone is effective in severe hemichorea–hemiballism. Mov Disord. 1999;14:377–378
  215. Hefter H, Mayer P, Benecke P. Persistent chorea after recurrent hypoglycemia. Eur Neurol. 1993;33:244–247
  216. Newman RP, Kinkle WR. Paroxysmal choreoathetosis due to hypoglycemia. Arch Neurol. 1984;41:34
  217. Schmidt BJ, Pillay N. Paroxysmal dyskinesia associated with hypoglycemia. Can J Neurol Sci. 1993;20:151–153
  218. Kurlan R. Postprandial (reactive) hypoglycemia and restless legs syndrome: related neurologic disorders?. Mov Disord. 1998;13:619–620
  219. Milanov I, Georgiev D, Todorov T. Clinical and electromyographic characteristics of tremor in patients with depression. Parkinsonism Relat Disord. 2000;6:101–105
  220. Fidler SM, O'Rourke RA, Buchsbaum HW. Choreoathetosis as a manifestation of thyrotoxicosis. Neurology. 1971;21:55–57
  221. Sánchez Fuentes A, Herraez J, Zurdo JR, Sánchez Rodríguez A, Alvarez J. Corea e hipertiroidismo. Rev Clin Esp. 1986;43:345–347
  222. Delwaide DJ, Schoenen J. Hyperthyroidism as a cause of persistent choreic movements. Acta Neurol Scand. 1978;58:309–363
  223. Yen J, Shan D-E, Lu S-R. Hyperthyroidism present as recurrent short paroxysmal kinesigenic dyskinesia. Mov Disord. 1998;13:361–363
  224. Donucelli U, D'Avino C, Caraccio N, del Guerra P, Casolaro A, Pavese N, et al. Thyroid function and autoimmunity in Parkinson's disease: a study of 101 patients. Parkinsonism Relat Disord. 1999;5:49–53
  225. Erickson JC, Carrasco H, Grimes JB, Jabbari B, Cannard KR. Palatal tremor and myorrythmias in Hashimoto's encephalopathy. Neurology. 2002;58:504–505
  226. Ghika-Smidt A, Ghika J, Regli N, Dworak N, Bougousslavsky J, Städler C, et al. Hashimoto encephalopahy: an underdiagnosed condition?. Mov Disord. 1996;11:555–562
  227. Shaw PJ, Walls TJ, Newman PK, Cleland PG, Cartlidge NEF. Hashimoto's encephalopathy: a steroid-responsive disorder associated with high anti-thyroid titers: report of 5 cases. Neurology. 1991;41:223–228
  228. Kothbauer-Margreiter I, Sturzenegger M, Komor J, Baumgartner S, Hess CW. Encephalopathy associated with Hashimoto's thyroiditis: diagnosis and treatment. J Neurol. 1996;243:585–593
  229. Klawans HL, Luptom M, Simon L. Calcification of the basal ganglia as a cause of levodopa-resistant Parkinsonism. Neurology. 1976;26:221–225
  230. Berger JR, Ross DV. Reversible parkinsonian syndrome complicating postoperative hypoparathyroidism. Neurology. 1981;31:881–882
  231. Tamebyah PK, Ong BKC, Lee KO. Reversible Parkinsonism and asymptomatic hypocalcemia with basal ganglia calcification from hypoparathyroidism 26 years after thyroid surgery. Am J Med. 1993;94:444–445
  232. Gálvez-Jiménez N, Hanson H, Cabral J. Dopa-resistant Parkinsonism, oculomotor disturbances, chorea, mirror movements, dyspraxia, and dementia: the expanding clinical spectrum of hypoparathyroidism. A case report. Mov Disord. 2000;15:1273–1276
  233. Friedman JH, Chiucchini JI, Tucci JR. Idiopathic hypoparathyroidism with extensive brain calcifications and persistent neurologic dysfunction. Neurology. 1987;37:307–309
  234. Ameneiros-Lago E, Macías-Arribi M, Fernández-Fernández FJ, Sesma-Sánchez P. Parkinsonismo y convulsiones secundarias a hipoaratiroidismo primario. Rev Neurol. 2001;32:198
  235. Papadimitriou CE, Avramidis T, Terentiou AE, Tzioras C, Divai P. Staff-person like syndrome in a patient with multiple pituitary hormone deficiencies. Acta Neurol Scand. 2000;102:403–405
  236. Louis MB, McQuillen G, Bumford JM, Houdle PD. Delayed myelopathic presentation of the acquired hepatocerebral degeneration syndrome. Neurology. 2000;54:1011
  237. Jog MS, Lang AE. Chronic acquired hepatocerbral degeneration: case reports and new insights. Mov Disord. 1995;10:714–722
  238. Condal B, Dusoleil A, Bernardeau M, Roche A, Pellet A. Chronic acquired hepatocerebral degeneration: the role of manganese and treatment by endovascular occlusion of a portal-systemic shunt. Gastroenterol Clin Biol. 1999;23:268–270
  239. Burkhard PR, Delavelle J, DuPasquiere R, Spahr L. Chronic Parkinsonism associated with cirrosis: a distinct subset of acquired hepatocerebral degeneration. Arch Neurol. 2003;60:521–528
  240. Thobois S, Giraud P, Debat P, Maurizi A, Pret-Liaudet A, Kopp NB, et al. Orofacial dyskinesias in a patient with primary biliary cirrhosis: clinicopathological case report and review. Mov Disord. 2002;17:415–419
  241. Demarquay G, Setiety A, Morel Y, Chaszot G, Brusolle E. Clinical report of three patients with hereditary hemochromatosis and movement disorders. Mov Disord. 2000;15:1204–1209
  242. Federico FP, Zochone DW. Reversible Parkinsonism and hyperammoniemia associated with portal vein thrombosis. Acta Neurol Scand. 2001;103:198–200
  243. Pujol A, Pujol J, Graus F, Peri J, Mercader JM, Rimola A. Hyperintensity of the globus pallidus on Ti-weighted and inversion-recovery MRI: a possible marker of advanced liver disease. Neurology. 1991;41:1526–1527
  244. Rovira A, Córdoba J, Sanpedro F, Grivé E, Rovira-Gols A, Alonso J. Normalization of T2 signal abnormalities in hemispheric white matter with liver transplant. Neurology. 2002;59:335–341
  245. Kulisevsky J, Pujol J, Junqué C, Deus J, Balanzó J, Capdevilla A. MRI pallidal hyperintensity and brain atrophy in cirrhotic patients. Two different MRI patterns of clinical deterioration?. Neurology. 1993;43:2570–2573
  246. Pujol A, Pujol J, Graus F, Rimola A, Peri J, Mercader JM, et al. Hyperintense globus pallidus on T1-weighted on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology. 1993;43:65–69
  247. Stracciari A, Guarino M, Pazzaglia P, Marcheisini G, Pisi P. Acquired hepatocerebral degeneration: full recovery after transplantation. J Neurol Neurosurg Psychiatry. 2001;70:132–141
  248. Wijdicks EFM, Wiesner RH, Krom RAF. Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression. Neurology. 1995;45:1962–1964
  249. Bird GLA, Meadows J, Goka J, Polson R, Williams R. Cyclosporine-associated akinetic mutism and extrapyramidal syndrome after liver transplantation. J Neurol Neurosurg Psychiatry. 1990;53:1068–1071
  250. LeDoux MS, Lora JM, Pulsinelli WA, Pfeiffer RF, Deuschl G, Siderow A, et al. Severe bilateral tremor in a liver transplant recipient taking cyclosporine. Mov Disord. 1998;13:589–596
  251. Toro C, Hallett M, Rothwell JC, Asselman PT, Marsden CD. Physiology of negative myoclonus. In:  Fahn S,  Hallett M,  Lüders HL,  Marsden CD editor. Negative motor phenomena. Advances of neurology. vol. 67:Philadelphia: Lippincott–Raven; 1995;p. 211–217
  252. Chadwick D, French AT. Uremic myoclonus: an example of reticular reflex myoclonus?. J Neurol Neurosurg Psychiatry. 1979;42:52–55
  253. Wetter TC, Sistiasny K, Kohnen R. Polysomnographic sleep measures in patients with uremic idiopathic restless legs syndrome. Mov Disord. 1998;13:820–824
  254. LaRochelle JS, Karp BI. Restless legs syndrome due to interferon-alpha. Mov Disord. 2004;19:730–731
  255. Wang H-C, Brown P, Lees AJ. Acute movement disorders with bilateral basal ganglia lesions in uraemia. Mov Disord. 1998;13:952–957

☆ Part of the article was presented at the Seventh International Congress of Parkinson's Disease and Movement Disorders, in Miami, Florida, USA, November 10–14, 2002.

PII: S1353-8020(04)00159-2

doi: 10.1016/j.parkreldis.2004.10.003

Parkinsonism & Related Disorders
Volume 11, Issue 1 , Pages 1-18 , January 2005

Article Tools

* Image Usage & Resolution